TRACON Pharmaceuticals In...

0.03
-0.00 (-6.83%)
At close: Feb 28, 2025, 3:00 PM
1.08
3254.04%
After-hours: Jun 27, 2024, 07:53 PM EDT

TRACON Pharmaceuticals Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
PE Ratio -1.59 -1.06 -1.66 -6.06 -0.31 -0.49 -2.95 -2.3 -4.21 -16.54 -0.6 -61.61
PEG Ratio 0.02 0.07 0.12 0.08 0.01 -0.03 0.06 0.77 -0.01 0.17 -0.00 n/a
PS Ratio 0.47 n/a 138.12 n/a n/a 5.66 6.43 18.01 12.99 31.29 n/a n/a
PB Ratio -7.06 -4.36 4.08 4.19 2.63 0.79 3.31 2.19 3.32 -3.5 -0.18 -17.19
P/FCF Ratio 1.55 -1.19 -2.11 -6.16 -0.3 -0.55 -4.24 -2.29 -5.32 66.70 -0.69 -55.8
P/OCF Ratio 1.55 -1.19 -2.12 -6.16 -0.3 -0.55 -4.25 -2.29 -5.36 64.04 -0.69 -55.9
OCF/S Ratio 0.31 n/a -65.23 n/a n/a -10.26 -1.51 -7.87 -2.42 0.49 n/a n/a
Debt / Equity Ratio -1.2 -1.37 0.12 0.18 1.98 0.30 0.44 0.26 0.29 -0.28 -0.1 n/a
Quick Ratio 0.89 0.81 1.82 3.50 1.46 3.01 3.06 4.46 3.76 2.70 1.16 3.87
Current Ratio 0.89 0.81 1.82 3.50 1.46 3.01 3.06 4.46 3.76 2.70 1.16 3.87
Asset Turnover 1.19 n/a 0.01 n/a n/a 0.07 0.24 0.08 0.15 0.09 n/a n/a
Interest Coverage -0.94 -28.06 -89.14 -29.77 -57.76 -150.39 -20.55 -23.21 -25.42 -9.26 -252 n/a
Return on Equity (ROE) 4.44 4.10 -2.45 -0.69 -8.4 -1.63 -1.12 -0.95 -0.79 0.21 0.30 0.28
Return on Assets (ROA) -0.36 -1.51 -1.08 -0.46 -1.25 -0.86 -0.53 -0.59 -0.46 -0.18 -3.19 -1.89
Return on Capital (ROIC) 89.58 9.61 -2.2 -0.6 -3.55 -1.28 -0.75 -0.73 -0.6 -0.25 -20.32 -2.69
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 99.88% n/a 95.95% n/a n/a -915.33% -121.07% -341.98% -158.48% -34.88% n/a n/a
Net Profit Margin -29.79% n/a -8.3K% n/a n/a -1.17K% -218.2% -783.07% -308.83% -189.24% n/a n/a
Pretax Profit Margin -29.79% n/a -8.29K% n/a n/a -1.17K% -218.2% -783.07% -308.83% -189.24% n/a n/a
Operating Profit Margin -57.27% n/a -8.19K% n/a n/a -1.16K% -208% -753.15% -296.9% -171.73% n/a n/a
FCF Margin 30.52% n/a -6.54K% n/a n/a -1.03K% -151.71% -787.27% -244.05% 46.91% n/a n/a
EBITDA Margin -57.15% n/a -8.19K% n/a n/a -1.16K% -207.53% -747.9% -296.26% -171.32% n/a n/a